Cj. Tornhage et al., PLASMA SOMATOSTATIN AND CHOLECYSTOKININ LEVELS IN PRETERM INFANTS DURING THEIR FIRST 2 YEARS OF LIFE, Pediatric research, 41(6), 1997, pp. 902-908
Plasma somatostatin and cholecystokinin are two gut peptides with oppo
site functions which are regulated by two different parts of the auton
omic nervous system. Previously we have shown that plasma somatostatin
and cholecystokinin levels are higher in preterm infants during the 1
st d of life than in adults or in their mothers, and that plasma somat
ostatin is negatively correlated to gestational age. We have longitudi
nally studied these two peptides in 28 preterm infants, 17 boys and 11
girls, up until the age of 2 y. The mean (SD) gestational age was 32.
3 (2.8) wk, the mean birth weight was 1877 (515) g, and the mean birth
length was 42.8 (3.8) cm Blood samples were taken on the 1st d of lif
e, at 6 wk, and at 3, 6, 12, and 24 mo of age. Plasma was analyzed by
specific somatostatin and cholecystokinin RIAs. The median plasma soma
tostatin and cholecystokinin levels were lowest at 3 mo (somatostatin
= 17.4/cholecystokinin = 10.5 pmol/L) and highest at 6 mo (somatostati
n = 37.3/cholecystokinin = 27.1 pmol/L). At 24 mo plasma somatostatin
remained at the same level: and cholecystokinin had decreased to half
that level. After the 1st d of life plasma somatostatin and cholecysto
kinin levels were not correlated to gestational age or attained weight
or length. The plasma somatostatin level at 3 mo of age was negativel
y correlated to the increment in knee-heel distance between 3 and 6 mo
of age.